ABSTRACT
Patients and methods: 20 patients
(13 males and 7 females) with pathologicall proven differentiated cancer thyroid were included in the study. All patients were subjected to near total thyroidectomy. 8 out of the 20 patients also underwent lymph node dissection. All received 131 I ablation and had a negative whole body scan during follow up. They had unexplained elevated (> 10 ng/ml or more) or rising serum Tg levels (5-10ng/ml). All patients were subjected to full history, clinical examination, Laboratory and radiological assessment as well as 18 F-FDG PET/CT study.
Results: Neck US detected 7 lesions in 6 patients, all of them confirmed to be positive by PET/CT and an additional 13 neck lesions were detected by PET/CT in 15 patients. CT chest detected 8 patients, 6 of them confirmed by PET/CT while 2 lung lesions were negative. Eight additional mediastinal lymph node metastases were detected by PET/CT. PET/CT showed positive findings in 19/20 patients. In the remaining no cause for the elevated Tg was found with PET/CT or other radiological methods. PET/CT directed the management in 14/20 patients either to surgery or to external radiotherapy with normalization of Tg level within weeks after treatment.
INTRODUCTION:
Differentiated thyroid cancer (Papillary and follicular) represents approximately 80%-85% of thyroid carcinoma. Both have an excellent prognosis, with a 20 years survival of 90%-95% and 75%, respectively [1] .
The standard surgical treatment is total (or near-total) thyroidectomy. This procedure decreases the risk of local recurrence and facilitates post-surgical radioiodine ablation and adequate follow up [2] .
A diagnostic scan with radio-active 131 I is usually obtained 4-6 weeks after surgery to demonstrate residual functioning thyroid remnant and/or metastases. The diagnostic 131 I dose typically ranges from 2-5 mCi (74-185MBq) and scanning is performed at 72 hours [3] .
Serum thyroglobulin (TG) appears to be the most sensitive test in the follow-up of differentiated cancer thyroid while other imaging methods as ultrasound and CT may be helpful with limited sensitivity [4] . 
PATIENTS AND METHODS:
This retrospective study was performed at the International Medical Center (IMC) during the period from January 2009 to December 2011.
This study included 20 patients (13 males and 7 females) with pathologically proven differentiated cancer thyroid. All patients underwent near total thyroidectomy. 8 out of the 20 patients underwent local lymph node dissection. All received 131 I ablation and they had negative whole body scan during follow up ,The WBS was performed administration of 2-5mCi (74-185MBq) 131 I orally, after 3-4 weeks cessation of Eltroxin. Also, included subject patients had unexplained elevated TG (> 10 ng/ml or more) or rising serum Tg levels (5-10 ng/ml).
The patients had a full history and clinical examination, especially the neck.
Laboratory and radiological done including Serum Tg level (with Tg antibody estimation), Fasting blood sugar to determine if the patient is diabetic, neck ultrasound and chest CT. PET/CT imaging: PET/CT was performed on an integrated 64 slice PET/CT scanner (Philips; Eindhoven, Netherlands). Patients were fasting for at least 6 hours before the PET/CT study. PET images were acquired during normal breathing in 3D mode for 4 minutes per bed position 60 minutes after intravenous administration of 0.1 mCi (3.7MBq 18 F-FDG /Kg. Interpretation of PET/CT scans were done independently by 2 experienced physicians blinded to the clinical situation and any disagreement was resolved by consensus. PET and fused PET/CT images were analyzed both qualitatively and semi quantitatively.
Qualitative evaluation: A visually abnormal focus of 18 F-FDG uptake was defined as focal uptake higher than surrounding tissue with no similar contralateral activity.
Semi-Quantitative evaluation:
A SUV max < 3 was considered normal while > 3 was considered abnormal.
Follow up:
Patients have been followed up clinically and the Tg level was estimated periodically at 6 months interval. Patients who underwent any changes in the Management in the form of either surgery or external radio-therapy, Tg was measured 4-6 weeks after management.
Follow up neck US, CT chest and PET/CT were done according to each patient status.
Statistical analysis:
Comparison of results of PET/CT with US and CT was done on both patients and a lesion by lesion basis.
RESULTS:
Thyroglobulin: All patients had elevated serum Tg level and negative anti Tg Abs. Tg was highly elevated (>10 ng/ml) in 14 patients and raised (5-10 ng/ml) in 6 patients ( Table 1 , Fig 1) .
In The PET/CT scan finding showed that in 6 patients with raised level of Tg (5-10 ng / ml), 4 showed loco-regional recurrence, while 2 patients had metastatic disease. Ten of 14 patients with Tg > 10 ng/ml had metastatic disease, while 3 patients showed locoregional recurrence and only one patient was negative on PET/CT (Table  1 , Fig 1) . (Fig 1) . One of these patients also had local recurrence in the thyroid bed. B) CT finding There were positive findings on CT in chest in 8 patients (6 patients with lung lesions and 2 patients with mediastinal lymphadenopathy). Two of the lung lesions were negative in PET/CT, while the other 6 lesions were positive on PET/CT (Table 2) . NB: One of the 6 US positive patients showed both cervical LNs and also local recurrence.
C) PET/CT findings:
The 18F-FDG PET/CT showed positive findings in 19/20 patients evaluated PET/CT showed that 7 patients had locoregional disease and 12 patients had metastasis lesions. Among the 12/20
patients that showed metastatic lesions on PET/CT, 17 sites of metastases were detected with the most common site being in the mediastinal lymph nodes (Table 3 Fig 2) . Table ( PET/CT found 14 metastatic lesions in the chest of 12 patients compared with 8 lesions detected by CT chest. PET/CT found 8 sites of active disease in the mediastinal LNs, CT found 2 lung lesions not detected by PET/CT (Table  4) . 
Follow up and outcomes of PET/CT findings:
PET/CT directed clinical management in 14/20 patients with favorable outcomes. 7 patients with only cervical LNs lesions had this was followed by normalization of Tg level 4-6 weeks after surgery. 5 other patients with only mediastinal LNs metastases and 2 patients with skeletal metastases were underwent external radiotherapy (30 -40 Gy in 3-4 weeks) with a reduction of Tg level within 6 weeks.
The patient with hepatic metastasis died within 6 months, while the remaining 4 patients with multiple metastatic lesions were lost in the follow up.
The only patient with no apparent explanation of elevated Tg neither on US, CT nor PET/CT showed unexplained spontaneous redaction of Tg in the follow up.
DISCUSSION
Treatment of DCT includes thyroidectomy and radioiodine ablation. A rising Tg following complete ablation is generally a reliable indicator of recurrent thyroid cancer. It assumed the presence of disease in patients with persistent elevated or rising Tg levels, although this assumption might not be true in all cases [2] .
An advantage of 18 F-FDG PET/CT whole body scanning is the ability with identification of thyroid cancer recurrences and metastases in soft tissue, lymph nodes, liver, lungs, and bone in a single imaging procedure. A crucial advantage of co-registered 18 F-FDG PET/CT is the precise localization of local recurrences and distant metastatic disease [1] .
In this work we found an overall high sensitivity of PET/CT for detecting and localizing recurrent or metastatic differentiated thyroid cancer (19/20 patients). Only one patient showed no possible explanation for the elevated Tg level neither on US, CT nor PET/CT. However, this patient showed reduction of Tg level in the follow up. These results compare favourably with a study of Schluter et al 64 DCT patients, 44 patients had positive PET/CT scans, which were proven to be true-positive in 34 patients, whereas 10 patients had false-positive findings. On the other hand, 20 patients had negative scans. These were true-negative findings in 5 patients, whereas the remaining 15 patients had false-negative results [6] .
In the present study, PET/CT was positive in 15 patients more superior than ultrasound in local recurrence.
Though an important observation is that ultrasound offers the advantage of immediate biopsy of suggestive lesions [7] .
Also we demonstrated that 8 patients had positive findings in CT chest (6 lung lesions and 2 mediastinal LNs lesions), 2 of the lung lesions were negative in PET/CT, while the other 6 lesions approved to be active on PET/CT. 4.Zakani, A., et al., Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups. European review for medical and pharmacological sciences, 15(10): p. 1215-21; 2011. 
